Cipher appoints new Chief Executive Officer
Cipher Pharmaceuticals Inc. announced that, effective August 8, 2006, Larry Andrews, President of Cipher, has been appointed Chief Executive Officer of the Company. Dr. John Mull has retired from the position of Chief Executive Officer, but will remain Chairman of the Board of Directors. Mr. Andrews has served as President of Cipher since 2004 and will retain responsibility for this function.
Mr. Andrews has more than 25 years of experience in the pharmaceutical industry. Prior to joining Cipher, he was the founder and President of the Health Alliance Group. The former President of AltiMed Pharmaceuticals, Mr. Andrews has played a lead role in the licensing of over 25 compounds in the Canadian pharmaceutical market. His career includes senior management assignments with Eli Lilly, Syntex Pharmaceuticals, and Hoffmann-La Roche.
Other news from the department people
